COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
Article
[키워드] adverse event
age
anaphylaxis
anti-cancer treatment
approval
Cancer
Cancer center
cancer patient
Cancer patients
Care
Chemotherapy
clinical trials
collected
COVID-19
COVID-19 vaccine
Emergency
exclusion
experience
fatigue
first dose
Follow-up
headache
Headaches
Immunotherapy
information
less
London
lung
Mild
Moderna
MOST
oncology
oncology patient
Patient
patients
Pfizer/BioNTech
Phase III trials
provide
reactogenicity
receiving
Safety
Side effect
Side effects
simple
solid malignancy
study period
the vaccine
tiredness
Vaccine
was collected
[DOI] 10.3390/cancers13143573 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cancers13143573 PMC 바로가기 [Article Type] Article